Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 110 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

24%

26 trials in Phase 3/4

Results Transparency

0%

0 of 56 completed trials have results

Key Signals

23 recruiting

Enrollment Performance

Analytics

Phase 1
43(39.1%)
Phase 2
38(34.5%)
Phase 3
23(20.9%)
N/A
3(2.7%)
Phase 4
3(2.7%)
110Total
Phase 1(43)
Phase 2(38)
Phase 3(23)
N/A(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (110)

Showing 20 of 110 trials
NCT07583849Phase 3Recruiting

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD

Role: lead

NCT07140328Phase 2Recruiting

Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)

Role: lead

NCT07634367Phase 3Not Yet Recruiting

Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD

Role: lead

NCT07623486Phase 1Active Not Recruiting

Trial of HSK44459 Cream for the Management Plaque Psoriasis

Role: lead

NCT07616375Phase 3Recruiting

A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Role: lead

NCT07616700Phase 2Recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy

Role: lead

NCT06670352Phase 2Completed

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Role: lead

NCT07533786Phase 2Recruiting

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

Role: lead

NCT07390123Phase 3Recruiting

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Role: lead

NCT07580794Phase 1Not Yet Recruiting

First-in-human Study of HSK56630 in Healthy Subjects

Role: lead

NCT07581951Phase 3Not Yet Recruiting

A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Role: lead

NCT07566663Not ApplicableNot Yet Recruiting

Preventive Analgesia With Anrikefon in Laparoscopic Cholecystectomy

Role: collaborator

NCT07561554Phase 1Recruiting

Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation

Role: lead

NCT07558967Phase 1Completed

Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects

Role: lead

NCT07551739Phase 2Not Yet Recruiting

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Role: lead

NCT07551713Phase 1Completed

Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects

Role: lead

NCT07519278Phase 1Completed

Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects

Role: lead

NCT06764862Phase 2Completed

Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis

Role: lead

NCT07519070Phase 3Not Yet Recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis

Role: lead

NCT07521345Phase 1Recruiting

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.

Role: lead